Correlation Between NexGel Warrant and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NexGel Warrant and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NexGel Warrant and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NexGel Warrant and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on NexGel Warrant and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NexGel Warrant with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NexGel Warrant and Lipella Pharmaceuticals.
Diversification Opportunities for NexGel Warrant and Lipella Pharmaceuticals
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NexGel and Lipella is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding NexGel Warrant and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and NexGel Warrant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NexGel Warrant are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of NexGel Warrant i.e., NexGel Warrant and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between NexGel Warrant and Lipella Pharmaceuticals
Assuming the 90 days horizon NexGel Warrant is expected to generate 11.04 times more return on investment than Lipella Pharmaceuticals. However, NexGel Warrant is 11.04 times more volatile than Lipella Pharmaceuticals Common. It trades about 0.11 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about -0.02 per unit of risk. If you would invest 30.00 in NexGel Warrant on August 25, 2024 and sell it today you would earn a total of 18.00 from holding NexGel Warrant or generate 60.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 71.2% |
| Values | Daily Returns |
NexGel Warrant vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| NexGel Warrant |
| Lipella Pharmaceuticals |
NexGel Warrant and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NexGel Warrant and Lipella Pharmaceuticals
The main advantage of trading using opposite NexGel Warrant and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NexGel Warrant position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| NexGel Warrant vs. Heartbeam | NexGel Warrant vs. EUDA Health Holdings | NexGel Warrant vs. Nutex Health | NexGel Warrant vs. Healthcare Triangle |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |